Suppr超能文献

组蛋白去乙酰化酶 (HDAC) 1 和 2 的生理作用:拥有多个领衔主演角色的复杂联合主演。

The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts.

机构信息

Department of Biochemistry, University of Leicester, Henry Welcome Building, Lancaster Road, Leicester LE1 9HN, U.K.

出版信息

Biochem Soc Trans. 2013 Jun;41(3):741-9. doi: 10.1042/BST20130010.

Abstract

HDACs (histone deacetylases) 1 and 2 are ubiquitous long-lived proteins, which are often found together in three major multiprotein co-repressor complexes: Sin3, NuRD (nucleosome remodelling and deacetylation) and CoREST (co-repressor for element-1-silencing transcription factor). Although there is a burgeoning number of non-histone proteins within the acetylome, these complexes contain multiple DNA/chromatin-recognition motifs, which, in combination with transcription factors, target HDAC1/2 to chromatin. Their physiological roles should therefore be viewed within the framework of chromatin manipulation. Classically, HDACs were thought to be recruited predominantly by transcriptional repressors to facilitate local histone deacetylation and transcriptional repression. More recently, genome-wide assays have mapped HDAC1/2 and their associated proteins to transcriptionally active loci and have provided alternative context-specific functions, whereby their repressive functions are subtly exerted to balance transcriptional activation and repression. With a few significant exceptions (early embryogenesis, brain development), HDAC1 and HDAC2 are functionally redundant. In most mouse knockout studies, deletion of both enzymes is required in order to produce a substantial phenotype. HDAC1/2 activity has been implicated in the development of numerous tissue and cell types, including heart, skin, brain, B-cells and T-cells. A common feature in all HDAC1/2-knockout, -knockdown and small-molecule inhibitor studies is a reduction in cell proliferation. A generic role in cell cycle progression could be exploited in cancer cells, by blocking HDAC1/2 activity with small-molecule inhibitors, making them potentially useful drug targets.

摘要

组蛋白去乙酰化酶(HDACs)1 和 2 是普遍存在的长寿蛋白,它们经常一起存在于三个主要的多蛋白共抑制复合物中:Sin3、NuRD(核小体重塑和去乙酰化)和 CoREST(元件 1 沉默转录因子的共抑制因子)。尽管乙酰基组中有大量的非组蛋白蛋白,但这些复合物含有多个 DNA/染色质识别基序,这些基序与转录因子结合,将 HDAC1/2 靶向染色质。因此,它们的生理作用应在染色质操作的框架内进行观察。经典上,HDACs 被认为主要通过转录抑制剂募集,以促进局部组蛋白去乙酰化和转录抑制。最近,全基因组测定将 HDAC1/2 及其相关蛋白映射到转录活跃的基因座,并提供了替代的特定于上下文的功能,其中它们的抑制功能被微妙地发挥,以平衡转录激活和抑制。除了少数重要的例外(早期胚胎发生、大脑发育)外,HDAC1 和 HDAC2 在功能上是冗余的。在大多数小鼠敲除研究中,需要删除两种酶才能产生显著的表型。HDAC1/2 的活性已被牵连到许多组织和细胞类型的发育中,包括心脏、皮肤、大脑、B 细胞和 T 细胞。所有 HDAC1/2 敲除、敲低和小分子抑制剂研究的一个共同特征是细胞增殖减少。通过使用小分子抑制剂阻断 HDAC1/2 活性,在癌细胞中可能会利用其在细胞周期进展中的一般作用,使其成为潜在的有用药物靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验